Inhibition of herpes simplex virus type 1 reproduction by probiotic bacteria in vitro

Voprosy Virusologii

Volumn 55, Issue 4, 2010, Pages 25-28

  Yermolenko, E I ^a   Furaeva, V A ^a   Isakov, V A ^b   Yermolenko, D K ^b   Suvorov, A N ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b ST PETERSBURG PASTEUR INSTITUTE   (Russian Federation)

Author keywords

Bacteriocins; Cytopathic effect; Enterococcl; Herpes simplex virus; Lactobacilli

Indexed keywords

ENTEROCOCCUS FAECIUM; ENTEROCOCCUS SP.; ESCHERICHIA COLI; HUMAN HERPESVIRUS 1; LACTOBACILLUS PLANTARUM; LACTOBACILLUS SP.; SIMPLEXVIRUS;

EID: 77956946437     PISSN: 05074088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Banasaz M., Norin E., Holma R., Midtved T. Increased enterocite production in gnotobiotic rats monoassociated with Lactobacillus rhamnosus GG // Appl. Environ. Microbiol. -2002. -Vol. 68. - P. 3031-3034.
2. Cinatl J. J., Cinatl J., Rabenau H., Gumbel H. et al. In vitro antihuman immunodeficiency activity of 2',3'-dideoxynucleotides and their effect on clonal growth of hemopoietic cells from human bone marrow // Arzneimittelforschung. -1993. -Bd 43, N 5. - S. 622-625.
3. Daher K, Selsted M. E., Lehrer R. I. Direct inactivation of viruses by human granulocyte defensins // J. Virol. -1986. -Vol. 60. - P. 1068-1074.
4. Hampl H., Schlehofer J. R., Habermehl K. O. Differences in the morphology of herpes simplex virus infected cells. II Type specific virus membrane alterations of HSV-1 and HSV-2 infected cells // Med. Microbiol. Immunol. - 1981. -Vol. 169, N 3.P. 209-223.
5. Kalla M., Isolauri E., Arvilommmi H, Vesikari T. Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhea // Arch. Dis. Childh. - 1995. - Vol. 72, N 1. - P. 43-51.
6. 2-generating bacteria: requirement for peroxidase and a halide // J. Infect. Dis. - 1974. - Vol. 129, N 3. - P. 345-348.
7. Klebanoff S. J., Coombs R. W. Virucidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heteroxesual transmission // J. Exp. Med. -1991. -Vol. 174. - P. 289-292.
8. Klebanoff S., Watts D. H., Mehlin C., Headley C. M. Lactobacilli and vaginal host defense: activation of the human immunodeficiency virus type 1 long terminal repeat, cytokine production, a NF-kB // J. Infect. Dis. - 1999. - Vol. 179. - P. 653-660.
9. Lehrer R. I., Daher K., Ganz T., Sehted M. E. Direct inactivation of viruses by MCP-1 and MCP-2, natural peptide antibiotics from rabbit leucocytes // J. Virol. -1985. -Vol. 54. -N 2. - P. 467-472.
10. Majamaa H., Isolauri E., Saxelin M., Vesikari T. Lactic acid bacteria in the treatment of cute rotavirus gastroenteritis // J. Pediatr. Gastroenterol. Nutr. -1995. -Vol. 20, N 3-P. 333-338.
11. Ohashi T., Minamishima Y., Yokokura T., Mutai M. Induction of resistance in mice against murine cytomegalovirus by cellular components of Lactobacillus casei // Biotherapy. -1989. -Vol. 1, N 2. - P. 89-95.
12. Rosenthal K. S., Killius J., Hodnlchak C. M. et al. Mild acidic pH inhibition of the major pathway of herpes simplex virus entry into HEp-2 cells // J. Gen. Virol. - 1989. - Vol. 70, N 4. -P. 857-867.
13. Klebanoff S. J., Watts D. H., Mehlin C., Headley C. M. Lactobacillus and vaginal host defense: activation of the human immunodeficiency virus type 1 long terminal repeat, cytokine production, and NF-kB // J. Infect. Dis. -1999. -Vol. 179. -P. 653-660.
14. Yasin B., Wang W., Pang M. et al. Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry // J. Virol. - 2004. - Vol. 78, N 10. -P. 5147-5156.
15. Yasui H., Kiyoshima J., Ho T., Shida K. Protection against influenza virus infection of mice fed Bifidobacterium breve YIT4064// Clin. Diagn. Lab. Immunol. - 1999. -Vol. 6, N 2. - P. 186-192.
16. Waschmann M. B., Farias M. E., Takeda E., Sesma F. et al. Antiviral activity of enterocin CRL35 aginst herpes viruses //J. Antimicrob. Agents. -1999. -Vol. 12. -P. 293-299.
17. Waschmann M. B., Castilla V., Holgado A. P. et al. Enterocin CRL35 inhibits late stages of HSV-1 and HSV-2 replication // Antiviral Res. - 2003. - Vol. 58, N 1. - P. 17-24.